DERMATOLOGICAL THERAPEUTIC MARKET ANALYSIS

Regional Analysis

Global Dermatological Therapeutic Market: Regional Insights

Based on geography, the global dermatological therapeutic market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, North America is expected to gain highest share in the market over the forecast period owing to the increasing incidence of skin diseases, increasing awareness among people, and government campaigns/initiatives to raise awareness in this region. For instance, according to the American Academy of Dermatology Association, acne is the most common skin condition in the United States, affecting around 50 million Americans annually. Moreover, there are more than 7.5 million people in the U.S. that have psoriasis. This in turn is expected to increase the demand for dermatological therapeutics in the region.

Europe is also expected to witness robust growth in the global dermatological therapeutic market due to the rise in burden of atopic dermatitis and strategic initiatives undertaken by the government and market players in this region. For instance, according to European Medicines Agency (EMA), European Union, in Europe, it is estimated that up to 7% of adults have atopic dermatitis and the proportion of adults with the moderate to severe form of the disease is around 30%. This in turn is expected to increase the demand for dermatological therapeutics in the region, driving the growth of the global dermatological therapeutic market.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa